Recent Trends-increasing the role of RT in salvage of HL
•
Radiation alone - obsolete
•
Combined modality programs -
decreasing
–
Radiation fields – markedly reduced
(ISRT by ILROG)
–
Radiation dose – from 40 Gy to 20-30 Gy
•
Chemotherapy alone -
increasing
–
Advanced-stage
–
Early-stage
(>50% of U.S. patients, most women)
•
New effective agents integrated in front line therapy
–
Brentuximab Vedotin
–
Check point inhibitors
`




